Related Experiment Video
Updated: Apr 17, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation
James E Scriven1, Joshua Rhein2, Katherine Huppler Hullsiek3
1Infectious Diseases Unit, GF Jooste Hospital, Cape Town Clinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa Liverpool School of Tropical Medicine, United Kingdom.
Introduction:
Earlier antiretroviral therapy (ART) initiation in cryptococcal meningitis resulted in higher mortality compared with deferred ART initiation (1-2 weeks vs 5 weeks postmeningitis diagnosis). We hypothesized this was due to ART-associated immune pathology, without clinically recognized immune reconstitution inflammatory syndrome.
Methods:
Three macrophage activation markers and 19 cytokines/chemokines were measured from cryopreserved cerebrospinal fluid (CSF) and serum during the Cryptococcal Optimal ART Timing (COAT) trial. Comparisons were made between trial arms (early vs deferred) at 1, 8, 14, and 21 days following meningitis diagnosis.
Results:
More participants with early ART initiation had CSF white cell count (WCC) ≥5/µL at day 14 (58% vs 40%; P = .047), after a median of 6-days ART. Differences were mainly driven by participants with CSF WCC <5/µL at meningitis diagnosis: 28% (10/36) of such persons in the early ART group had CSF WCC ≥5/µL by day 14, compared with 0% (0/27) in the deferred arm (P = .002). Furthermore, Kampala participants (the largest site) receiving early ART had higher day-14 CSF levels of interleukin-13 (P = .04), sCD14 (P = .04), sCD163 (P = .02), and CCL3/MIP-1α (P = .02), suggesting increased macrophage/microglial activation.
Conclusions:
Early ART initiation in cryptococcal meningitis increased CSF cellular infiltrate, macrophage/microglial activation, and T helper 2 responses within the central nervous system. This suggests that increased mortality from early ART in the COAT trial was immunologically mediated.
Insights
Starting antiretroviral therapy (ART) earlier for cryptococcal meningitis increased immune responses in the central nervous system, potentially explaining higher mortality. Deferred ART initiation showed lower immune activation and mortality.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Earlier antiretroviral therapy (ART) initiation in cryptococcal meningitis was linked to increased mortality compared to deferred initiation.
- This higher mortality was hypothesized to stem from ART-associated immune pathology, distinct from clinically apparent immune reconstitution inflammatory syndrome.
Purpose of the Study:
- To investigate the immunological mechanisms underlying increased mortality associated with early ART in cryptococcal meningitis.
- To compare immune activation markers in cerebrospinal fluid (CSF) and serum between early and deferred ART initiation groups.
Main Methods:
- The study analyzed macrophage activation markers and cytokines/chemokines in CSF and serum from the Cryptococcal Optimal ART Timing (COAT) trial.
- Measurements were taken at multiple time points (1, 8, 14, 21 days) post-meningitis diagnosis, comparing early versus deferred ART arms.
Main Results:
- Early ART initiation led to a higher incidence of elevated CSF white cell count (WCC) by day 14, particularly in patients with initially low WCC.
- Increased levels of interleukin-13, sCD14, sCD163, and CCL3/MIP-1α were observed in the CSF of patients receiving early ART, indicating heightened macrophage/microglial activation.
- These immunological changes were more pronounced in participants from the Kampala site.
Conclusions:
- Early ART initiation in cryptococcal meningitis promotes increased cellular infiltration and macrophage/microglial activation within the central nervous system.
- The findings suggest that the increased mortality observed with early ART in the COAT trial is immunologically mediated, likely due to exacerbated inflammatory responses.
More Related Videos
12:07A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
Published on: September 19, 2010
10:02Visualizing Non-lytic Exocytosis of Cryptococcus neoformans from Macrophages Using Digital Light Microscopy
Published on: October 21, 2014
Related Concept Videos
Brain Abscess l: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis